Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...
Targeted radiation therapy might be a safer way to treat a potentially dangerous heart rate problem, a new study says. Radiation therapy treated ventricular tachycardia as well as a standard but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback